Related Experiment Videos
[The renin-angiotensin system and post-ischemic angiogenesis]
Jean Sébastien Silvestre1, Bernard I Lévy
1INSERM U541, Hôpital Lariboisière, 41 Bd de la Chapelle, 75010 Paris.
Bulletin De L'Academie Nationale De Medecine
|December 14, 2004
Summary
This study explores how ischemia triggers new blood vessel growth, highlighting the roles of growth factors, inflammatory agents, and the renin-angiotensin system. Novel therapeutic strategies targeting this system show promise for treating ischemic conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Pharmacology
Context:
- Ischemia, a condition of reduced blood flow, significantly impacts tissue health and function.
- Neovascularization, the formation of new blood vessels, is a critical adaptive response to ischemia.
- Understanding the molecular mechanisms driving neovascularization is key to developing effective therapies.
Purpose:
- To summarize the primary mechanisms of ischemia-induced neovascularization.
- To investigate the role of angiotensin II and its receptors (AT1 and AT2) in angiogenesis.
- To explore the pro-angiogenic effects of angiotensin-converting-enzyme inhibitors through bradykinin pathways.
Summary:
- Growth factors and inflammatory agents are major drivers of neovascularization following ischemia.
- Angiotensin II exhibits dual effects: pro-angiogenic via AT1 receptors and anti-angiogenic/pro-apoptotic via AT2 receptors.
- Angiotensin-converting-enzyme inhibitors can promote angiogenesis by increasing bradykinin, leading to nitric oxide release.
Impact:
- Identifies key molecular players in ischemia-induced neovascularization.
- Reveals the complex, often opposing, roles of angiotensin II subtypes in blood vessel formation.
- Suggests novel therapeutic avenues targeting the renin-angiotensin system for treating pathological tissue ischemia, complementing existing gene and cellular therapies.